Lazard Asset Management LLC Invitae Corp Transaction History

Lazard Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$2.13 - $9.01 $9,378 - $39,671	4,403 Added 48.13%	13,551 $33,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $57,449 - $142,617	9,148 New	9,148 $72,000
Q4 2021 Feb 09, 2022	SELL	$14.7 - $28.67 $35,206 - $68,664	-2,395 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $2,625 - $3,628	-108 Reduced 4.31%	2,395 $68,000
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $674,635 - $1.04 Million	-25,858 Reduced 91.17%	2,503 $84,000
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $1.01 Million - $1.74 Million	-30,490 Reduced 51.81%	28,361 $1.08 Million
Q4 2020 Feb 11, 2021	BUY	$39.09 - $57.4 $2.3 Million - $3.38 Million	58,851 New	58,851 $2.46 Million
Q1 2020 May 14, 2020	SELL	$7.64 - $27.5 $2,490 - $8,965	-326 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$15.02 - $20.57 $3,755 - $5,142	-250 Reduced 43.4%	326 $5,000
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $3.86 Million - $5.64 Million	-204,974 Reduced 99.72%	576 $11,000
Q2 2015 Jul 08, 2019	BUY	N/A	205,550	205,550 $3.06 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.